Antagonism between C/EBPβ and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The commitment of multipotent cells to particular developmental pathways requires specific changes in their transcription factor complement to generate the patterns of gene expression characteristic of specialized cell types. We have studied the role of the GATA cofactor Friend of GATA (FOG) in the differentiation of avian multipotent hematopoietic progenitors. We found that multipotent cells express high levels of FOG mRNA, which were rapidly down-regulated upon their C/EBPβ-mediated commitment to the eosinophil lineage. Expression of FOG in eosinophils led to a loss of eosinophil markers and the acquisition of a multipotent phenotype, and constitutive expression of FOG in multipotent progenitors blocked activation of eosinophil-specific gene expression by C/EBPβ. Our results show that FOG is a repressor of the eosinophil lineage, and that C/EBP-mediated down-regulation of FOG is a critical step in eosinophil lineage commitment. Furthermore, our results indicate that maintenance of a multipotent state in hematopoiesis is achieved through cooperation between FOG and GATA-1. We present a model in which C/EBPβ induces eosinophil differentiation by the coordinate direct activation of eosinophil-specific promoters and the removal of FOG, a promoter of multipotency as well as a repressor of eosinophil gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 2×
“Production of and infection with recombinant E26 virus was performed as described (McNagny and Graf 1997).”
MethodZhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 2×
“In addition, mice lacking the C/EBP transcription factor have no mature eosinophils (Zhang et al. 1997); so far, the requirement for C/EBP or GATA-1 during eosinophil differentiation has not been addressed genetically.”
BackgroundFujiwara, Y., Browne, C. P., Cunniff, K., Goff, S. C., & Orkin, S. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12355 · Cited by 778
Self-citationTranscription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“Myeloid cell types (neutrophil granulocytes and macrophages) are characterized by the expression of PU.1 and C/EBP transcription factors, which regulate most myeloid-specific promoters (for review, see Tenen et al. 1997), as well as the absence of GATA-1 expression.”
BackgroundTsang, A. P., Visvader, J. E., Turner, C. A., Fujiwara, Y., Yu, C., Weiss, M. J., Crossley, M., & Orkin, S. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80318-9 · Cited by 712
Self-citationNegative cross-talk between hematopoietic regulators: GATA proteins repress PU.1
Zhang, P., Behre, G., Pan, J., Iwama, A., Wara-aswapati, N., Radomska, H. S., Auron, P. E., Tenen, D. G., & Sun, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8705 · Cited by 459
PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors
Nerlov, C., & Graf, T. (1998) · Genes & Development · doi:10.1101/gad.12.15.2403 · Cited by 449 · cited 8×
“In the case of PU.1-mediated myeloid commitment, loss of GATA-1 is followed by up-regulation of C/EBP (Nerlov and Graf 1998), which in turn may down-regulate FOG, leading to the wellknown C/EBP +PU.1 no GATA configuration of myeloid cell types.”
BackgroundInfluentialSelf-citationKulessa, H., Frampton, J., & Graf, T. (1995) · Genes & Development · doi:10.1101/gad.9.10.1250 · Cited by 418
Self-citationNerlov, C., Querfurth, E., Kulessa, H., & Graf, T. (2000) · Blood · doi:10.1182/blood.v95.8.2543 · Cited by 366 · cited 7×
“…up-regulation of endogenous GATA-1 in reprogrammed myeloblasts (Kulessa et al. 1995) prevents determination of the expression levels of the exogenously supplied GATA-1 proteins, we have found previously that mutations in the NF and CF of GATA-1 do not affect protein stability (Nerlov et al. 2000).”
BackgroundInfluentialSelf-citationGATA‐1 but not SCL induces megakaryocytic differentiation in an early myeloid line.
Visvader, J. E., Elefanty, A. G., Strasser, A., & Adams, J. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05557.x · Cited by 189 · cited 2×
“2000), and the ectopic expression of GATA-1 in myeloid cells leads to their loss of myeloid gene expression and acquisition of a thrombocytic/multipotent (at high GATA-1 levels) or eosinophil phenotype (at intermediate GATA-1 levels) (Visvader et al. 1992; Kulessa et al. 1995).”
BackgroundDNA binding by c‐Ets‐1, but not v‐Ets, is repressed by an intramolecular mechanism.
Lim, F., Kraut, N., Framptom, J., & Graf, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05096.x · Cited by 137
Self-citationDistinct C/EBP functions are required for eosinophil lineage commitment and maturation
Nerlov, C., McNagny, K. M., Döderlein, G., Kowenz-Leutz, E., & Graf, T. (1998) · Genes & Development · doi:10.1101/gad.12.15.2413 · Cited by 119 · cited 10×
“To correlate the down-regulation of FOG expression to eosino- GENES & DEVELOPMENT 2519 phil lineage commitment, we generated pools of primary MEPs transformed by the E26– ER virus expressing the C/EBP –ER fusion (Nerlov et al. 1998), as well as control MEPs transformed by wild-type E26 virus.”
BackgroundMethodSelf-citationMüller, C., Kowenz‐Leutz, E., Grieser‐Ade, S., Graf, T., & Leutz, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00303.x · Cited by 91 · cited 4×
“FOG is down-regulated during C/EBP -mediated eosinophil lineage commitment of multipotent progenitors The differentiation of MEPs along the eosinophil lineage can be efficiently induced by the C/EBP transcription factor (Müller et al. 1995; Nerlov et al. 1998).”
BackgroundMethodSelf-citationYamaguchi, Y., Nishio, H., Kishi, K., Ackerman, S. J., & Suda, T. (1999) · Blood · doi:10.1182/blood.v94.4.1429 · Cited by 65 · cited 4×
“The EOS47 and MBP are the most well-characterized eosinophil-specific promoters, and both of these are cooperatively activated by C/EBP and GATA-1 (McNagny et al. 1998; Yamaguchi et al. 1999).”
BackgroundResultInfluential
Cited by
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570
Self-citationForcing cells to change lineages
Graf, T., & Enver, T. (2009) · Nature · doi:10.1038/nature08533 · Cited by 899
Self-citationYu, C., Cantor, A. B., Yang, H., Browne, C., Wells, R. A., Fujiwara, Y., & Orkin, S. H. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020656 · Cited by 600
Self-citationTranscriptional regulation of erythropoiesis: an affair involving multiple partners
Cantor, A. B., & Orkin, S. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205326 · Cited by 594
Self-citationDiversification of haematopoietic stem cells to specific lineages
Orkin, S. H. (2000) · Nature Reviews Genetics · doi:10.1038/35049577 · Cited by 565
Self-citation
Metadata
- Authors
- Querfurth, E., Schuster, M., Kulessa, H., Crispino, J. D., Döderlein, G., Orkin, S. H., Graf, T., & Nerlov, C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-10-01
- Volume
- 14
- Issue
- 19
- Pages
- 2515-2525
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2151965925
- Cited by
- 122
- References
- 15
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.